Published in Environ Health Perspect on March 01, 2006
Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev (2010) 1.81
A toxicology for the 21st century--mapping the road ahead. Toxicol Sci (2009) 1.22
Toxicogenomics in regulatory ecotoxicology. Environ Sci Technol (2006) 1.11
The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58. Altern Lab Anim (2006) 0.97
Gene and protein expression following exposure to radiofrequency fields from mobile phones. Environ Health Perspect (2008) 0.95
Insulin resistance and environmental pollutants: experimental evidence and future perspectives. Environ Health Perspect (2013) 0.93
Integrating omic technologies into aquatic ecological risk assessment and environmental monitoring: hurdles, achievements, and future outlook. Environ Health Perspect (2010) 0.93
The human toxome project. ALTEX (2015) 0.88
An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratories. BMC Biotechnol (2011) 0.83
Transcriptional response of zebrafish embryos exposed to neurotoxic compounds reveals a muscle activity dependent hspb11 expression. PLoS One (2011) 0.82
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
Functional discovery via a compendium of expression profiles. Cell (2000) 31.39
Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 16.75
ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res (2003) 15.48
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
Independence and reproducibility across microarray platforms. Nat Methods (2005) 6.26
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
CIBEX: center for information biology gene expression database. C R Biol (2004) 6.16
Standards for microarray data. Science (2002) 4.11
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet (2003) 3.78
ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect (2003) 3.39
Molecular portraits and the family tree of cancer. Nat Genet (2002) 3.28
Standards for microarray data: an open letter. Environ Health Perspect (2004) 3.15
Universal RNA reference materials for gene expression. Clin Chem (2004) 2.53
Gene expression analysis reveals chemical-specific profiles. Toxicol Sci (2002) 2.50
Comprehensive comparison of six microarray technologies. Nucleic Acids Res (2004) 2.50
Database development in toxicogenomics: issues and efforts. Environ Health Perspect (2004) 2.26
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol (2001) 1.91
Prediction of compound signature using high density gene expression profiling. Toxicol Sci (2002) 1.82
Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci (2003) 1.64
Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J (2002) 1.63
Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences. EHP Toxicogenomics (2003) 1.54
Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol (2001) 1.52
Discriminating different classes of toxicants by transcript profiling. Environ Health Perspect (2004) 1.16
Confirming microarray data--is it really necessary? Genomics (2004) 1.12
Simultaneously monitoring gene expression kinetics and genetic noise in single cells by optical well arrays. Anal Chem (2004) 1.11
A modular approach to the ECVAM principles on test validity. Altern Lab Anim (2004) 1.04
Cross-site comparison of gene expression data reveals high similarity. Environ Health Perspect (2004) 1.01
Toxicogenomics: challenges and opportunities. Toxicol Lett (2003) 0.89
Standardization Initiatives in the (eco)toxicogenomics domain: a review. Comp Funct Genomics (2004) 0.87
Correlation of simultaneous differential gene expression in the blood and heart with known mechanisms of adriamycin-induced cardiomyopathy in the rat. Toxicol Pathol (2002) 0.82
RNA reference materials for gene expression studies. RNA metrology: forecast calls for partial clearing. Clin Chem (2004) 0.77
The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol (2007) 35.41
The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol (2008) 31.04
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res (2003) 15.48
Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol (2008) 12.96
ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res (2008) 12.45
The MGED Ontology: a resource for semantics-based description of microarray experiments. Bioinformatics (2006) 7.37
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol (2006) 5.92
FACT facilitates transcription-dependent nucleosome alteration. Science (2003) 5.83
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics (2010) 5.60
Modeling biomedical experimental processes with OBI. J Biomed Semantics (2010) 5.36
CD36 is a sensor of diacylglycerides. Nature (2005) 5.20
Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14
Toward interoperable bioscience data. Nat Genet (2012) 4.72
Megascience. 'Omics data sharing. Science (2009) 4.36
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15
The Genomic Standards Consortium. PLoS Biol (2011) 3.99
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93
Submission of microarray data to public repositories. PLoS Biol (2004) 3.83
Development of FuGO: an ontology for functional genomics investigations. OMICS (2006) 3.59
The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics. Nat Biotechnol (2007) 3.55
A strategy capitalizing on synergies: the Reporting Structure for Biological Investigation (RSBI) working group. OMICS (2006) 3.51
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol (2008) 3.43
MetaboLights--an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res (2012) 3.32
Standards for microarray data: an open letter. Environ Health Perspect (2004) 3.15
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem (2006) 2.90
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A (2005) 2.82
QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev Mol Diagn (2004) 2.73
Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. OMICS (2006) 2.72
The metabolomics standards initiative. Nat Biotechnol (2007) 2.54
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics (2008) 2.54
Comprehensive comparison of six microarray technologies. Nucleic Acids Res (2004) 2.50
Innate immunity in Arabidopsis thaliana: lipopolysaccharides activate nitric oxide synthase (NOS) and induce defense genes. Proc Natl Acad Sci U S A (2004) 2.40
Database development in toxicogenomics: issues and efforts. Environ Health Perspect (2004) 2.26
Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop Med Int Health (2009) 2.21
Toward a standards-compliant genomic and metagenomic publication record. OMICS (2008) 2.11
Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell (2005) 2.10
High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology (2013) 2.02
Microarray scanner calibration curves: characteristics and implications. BMC Bioinformatics (2005) 2.02
Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples. BMC Bioinformatics (2008) 1.98
Towards BioDBcore: a community-defined information specification for biological databases. Nucleic Acids Res (2010) 1.97
Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med (2002) 1.93
Survey-based naming conventions for use in OBO Foundry ontology development. BMC Bioinformatics (2009) 1.90
Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect (2004) 1.84
ArrayExpress: a public database of gene expression data at EBI. C R Biol (2004) 1.78
EBI metagenomics--a new resource for the analysis and archiving of metagenomic data. Nucleic Acids Res (2013) 1.74
GOFFA: gene ontology for functional analysis--a FDA gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics (2006) 1.72
ArrayTrack: an FDA and public genomic tool. Methods Mol Biol (2009) 1.71
Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential. Curr Opin Biotechnol (2007) 1.71
Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl Environ Microbiol (2005) 1.71
L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol (2004) 1.70
DNA microarrays are predictive of cancer prognosis: a re-evaluation. Clin Cancer Res (2010) 1.69
Meeting report: the fifth Genomic Standards Consortium (GSC) workshop. OMICS (2008) 1.66
High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med (Berl) (2003) 1.66
Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci (2003) 1.64
Annotation of environmental OMICS data: application to the transcriptomics domain. OMICS (2006) 1.62
Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc Natl Acad Sci U S A (2008) 1.62
Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol (2008) 1.61
Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol (2003) 1.61
Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ Health Perspect (2003) 1.60
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. Int J Cancer (2013) 1.60
"ToxRTool", a new tool to assess the reliability of toxicological data. Toxicol Lett (2009) 1.54
MetaboLights: towards a new COSMOS of metabolomics data management. Metabolomics (2012) 1.53
Mining FDA drug labels using an unsupervised learning technique--topic modeling. BMC Bioinformatics (2011) 1.53
Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52. Altern Lab Anim (2005) 1.52
The genomic standards consortium: bringing standards to life for microbial ecology. ISME J (2011) 1.52
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol (2005) 1.49
mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci (2009) 1.49
Report from the in vitro micronucleus assay working group. Mutat Res (2003) 1.47
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol (2011) 1.46
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations. Infect Immun (2002) 1.46
Standardizing data. Nat Nanotechnol (2013) 1.44
Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia. J Infect Dis (2003) 1.44
Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood (2003) 1.43
Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect (2013) 1.42
FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today (2011) 1.42
Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds. Mutat Res (2008) 1.41
Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci (2004) 1.41
Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Chem Res Toxicol (2011) 1.41
Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev Biol (2005) 1.41
Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol (2002) 1.39
Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. BMC Med Genomics (2012) 1.39
Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect (2012) 1.38
OntoMaton: a bioportal powered ontology widget for Google Spreadsheets. Bioinformatics (2012) 1.37
Detailed review of transgenic rodent mutation assays. Mutat Res (2005) 1.36
Technical reproducibility of genotyping SNP arrays used in genome-wide association studies. PLoS One (2012) 1.36
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop. Stand Genomic Sci (2010) 1.35
Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol (2005) 1.35
Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology (2005) 1.34
Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol (2002) 1.34
Next-generation sequencing and its applications in molecular diagnostics. Expert Rev Mol Diagn (2011) 1.33
Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol (2002) 1.32
Feedback loops comprising Dll1, Dll3 and Mesp2, and differential involvement of Psen1 are essential for rostrocaudal patterning of somites. Development (2003) 1.32